Inventor · Emeryville, CA, US

Karin Jooss

29Patents
9h-index
39Co-inventors
75Inventor score

Filing activity: Jun 3, 2003 → Jan 4, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US8287856B2 PD-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof Human Necessities 48 Active
US8580247B2 PS-1 antibodies in combination with a cytokine-secreting cell and methods of use thereof Human Necessities 31 Active
US7498024B2 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site Chemistry; Metallurgy 21 Expired
US7186699B2 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes Chemistry; Metallurgy 19 Expired
US7709224B2 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site Chemistry; Metallurgy 16 Expired
US7485291B2 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof Chemistry; Metallurgy 14 Expired
US7919079B2 Cancer immunotherapy compositions and methods of use Human Necessities 13 Active
US7714119B2 AAV vector compositions and methods for enhanced expression of immunoglobulins using the same Chemistry; Metallurgy 10 Expired
US7662623B2 Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site Chemistry; Metallurgy 9 Active
US8840881B2 Methods and compositions for treating prostate cancer or inducing a humoral immune response against prostate cancer Human Necessities 6 Active
US8425897B2 Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use Human Necessities 5 Active
US9066898B2 Prostate-associated antigens and vaccine-based immunotherapy regimens Chemistry; Metallurgy 4 Active
US7632509B2 Methods to express recombinant proteins from lentiviral vectors Chemistry; Metallurgy 3 Active
US9468672B2 Prostate-associated antigens and vaccine-based immunotherapy regimens Chemistry; Metallurgy 2 Active
US7939271B2 Methods and compositions for identifying prostate cancer or a humoral immune response against prostate cancer Physics 2 Active
US7901902B2 Methods and compositions for identifying a cellular immune response against prostate cancer Human Necessities 2 Active
US10660953B2 Anti-PD-1 antibodies and methods of use thereof Chemistry; Metallurgy 1 Active
US11110158B2 Prostate-associated antigens and vaccine-based immunotherapy regimens Chemistry; Metallurgy 1 Active
US12098383B2 Modified adenoviruses Chemistry; Metallurgy 0 Active
US11058753B2 Cancer vaccines Chemistry; Metallurgy 0 Active
US11591619B2 Modified adenoviruses Chemistry; Metallurgy 0 Active
US11510973B2 Alphavirus antigen vectors Chemistry; Metallurgy 0 Active
US12109257B2 Alphavirus neoantigen vectors Chemistry; Metallurgy 0 Active
US10251944B2 Cancer vaccines Chemistry; Metallurgy 0 Active
US11504421B2 Alphavirus neoantigen vectors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.